Vnitr Lek 2011, 57(3):243-247

Left ventricular end-systolic wall stress during antihypertensive treatment

J. Bulas1,*, J. Murín1, I. Janiga2, K. Kozlíková3
1 I. interná klinika Lekárskej fakulty UK a UN Bratislava, Slovenská republika, prednostka doc. MUDr. Soňa Kiňová, PhD.
2 Slovenská technická univerzita Bratislava, Slovenská republika, dekan prof. Ing. Ľubomír Šóoš, PhD.
3 Ústav lekárskej fyziky, biofyziky, informatiky a telemedicíny Lekárskej fakulty UK Bratislava, Slovenská republika, prednostka prof. MUDr. Elena Kukurová, CSc.

Introduction:
The mechanical load of left the ventricular wall by blood pressure generated during systole causes a strain associated with the impedance to ventricular emptying. Among several indices, the circumferential systolic wall stress is used to describe this load. The calculated stress depends on systolic blood pressure, wall thickness and ventricular cavity dimension. Methods enabling noninvasive quantification of those indices are based on echocardiographic examinations and blood pressure measurements. Left ventricular hypertrophy in hypertension is considered as a compensatory mechanism allowing the heart to withstand the hemodynamic strain associated with increased arterial pressure.

Subjects and methods:
In the group of 25 female patients with treated arterial hypertension with suboptimal blood pressure levels in the initial evaluation, we realized echocardiographic examination and calculated left ventricular mean circumferential systolic wall stress. The re-evaluation was done after achieving the target blood pressure levels (below 140/90 mm Hg) in the time interval of 6 month to 2 years.

Results:
The statistically significant decrease of systolic wall stress was mainly due to lowering of blood pressure. The next favourable factor was diminishing of the left ventricular end-diastolic diameter, though the difference was not statically significant. By the multiple regression analysis we found that the final significant lowering of systolic wall stress was influenced also by favourable geometrical remodelling of the left ventricle by the tendency of diminishing of left ventricular diastolic diameter and the increase of relative wall thickness.

Conclusion:
We considered repeated echocardiographic examination and the systolic wall stress calculation (which integrates the ventricular geometry with the blood pressure values achieved) as an appropriate parameter for evaluation of the effect of antihypertensive therapy in the long-term management of hypertensive patients.

Keywords: systolic wall stress; arterial hypertension; echocardiography

Received: January 13, 2011; Published: March 1, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bulas J, Murín J, Janiga I, Kozlíková K. Left ventricular end-systolic wall stress during antihypertensive treatment. Vnitr Lek. 2011;57(3):243-247.
Download citation

References

  1. Kaplan NM. Kaplan's Clinical Hypertension. 8th ed. Philadelphia: Lippincott Williams and Wilkins 2002.
  2. Devereux RB, Alderman MH. Role of Preclinical Cardiovascular Disease in the Evolution From Risk Factor Exposure to Development of Morbid Events. Circulation 1993; 88: 1444-1455. Go to original source... Go to PubMed...
  3. Mancia G, Backer G, Domincziak A et al. 2007 Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25: 1105-1187. Go to original source... Go to PubMed...
  4. Berk BG, Fujiwara K, Lehgoux S. ECM remodeling in hypertensive heart disease. J Clin Invest 2007; 117: 568-575. Go to original source... Go to PubMed...
  5. Ganau A, Devereux RB, Roman MJ et al. Patterns of left ventricular hypertrophy and remodeling in essential hypertension. J Am Coll Cardiol 1992; 19: 1550-1558. Go to original source... Go to PubMed...
  6. Prisant M. Hypertensive heart disease. J Clin Hypertens 2005; 7: 231-238. Go to original source... Go to PubMed...
  7. Rysä J, Aro J, Ruskoaho H. Early left ventricular gene expression profile in response to increase in blood pressure. Blood Press 2006; 15: 375-383. Go to original source... Go to PubMed...
  8. Sugishita Y, Iida K, Ohtsuka O et al. Ventricular Wall stress revisted. A keystone of Cardiology. Jpn Hear J 1994; 35: 577-587. Go to original source... Go to PubMed...
  9. Hurlburt HM, Aurigema GP, Hill JC et al. Direct ultrasound measurement of longitudinal, circumferential and radial strain using 2-dimensional strain imaging in normal adults. Echocardiography 2007; 24: 723-731. Go to original source... Go to PubMed...
  10. Blake J, Devereux RB, Herrold EM et al. Relation of concentric left ventricular Hypertrophy and extracardiac target organ damage to supranormal left ventricular performance in estabilished hypertension. Am J Cardiol 1988; 62: 246-252. Go to original source... Go to PubMed...
  11. Lee R, Kamm RD. Vascular mechanics for the cardiologist. JACC 1994; 23: 1289-1295. Go to original source... Go to PubMed...
  12. White E. Mechanosensitive channels: Therapeutic targets in the myocardium? Curr Pharmacol Design 2006; 12: 3645-3663. Go to original source... Go to PubMed...
  13. Celentano A, Pietropaolo I, Plamieri V et al. Inappropriate left ventricular mass and angiotensin converting enzyme gene polymorphism. J Human Hypertens 2001; 15: 811-813. Go to original source... Go to PubMed...
  14. Devereux RB, Alonso RD, Lutas EM et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy finding. Am J Cardiol 1986; 57: 450-458. Go to original source... Go to PubMed...
  15. Quinones M, Mokotoff DM, Nouri S et al. Noninvasive quantification of left ventricular wall stress. Validation of method and application to assessment of chronic pressure overload. Am J Cardiol 1980; 45: 782-790. Go to original source... Go to PubMed...
  16. Statgraphics® PLUS, version 3 for Windows. User manual. Rockville: Manugistics, Inc., 1997. 738 p.
  17. Schmieder RE, Messerli F, Sturgill D et al. Cardiac performance after reduction of myocardial hypertrophy. Am J Med 1989; 87: 22-27. Go to original source... Go to PubMed...
  18. Opie HL, Commerford PJ, Gersh BJ et al. Controversies in ventricular remodelling. Lancet 2006; 367: 356-367. Go to original source... Go to PubMed...
  19. Niederle P, Cífková R, Widimský J et al. Echokardiografické sledování regrese zbytnění srdeční svaloviny během účinné a dlouhodobé antihypertenzní léčby. Vnitř Lék 1985; 31: 1050-1057. Go to PubMed...
  20. Perlini S, Muiesan ML, Cuspidi C et al. Midwall mechanics are improved after regression of hypertensive left ventricular hypertrophy and normalization of chamber geometry. Circulation 2001; 103: 678-683. Go to original source... Go to PubMed...
  21. Moyssakis I, Moschos N, Triposkiadis F et al. Left ventricular end-systolic stress/diameter relation as a contractility index and as a predictor of survival. Independence of preload after normalisation for end-diastolic diameter. Heart Vessels 2005; 20: 191-198. Go to original source... Go to PubMed...
  22. de Gregorio C, Micari A, Di Bella G et al. Systolic wall stress may affect the intramural coronary blood flow velocity in myocardial hypertrophy, independently on the left ventricular mass. Echocardiography 2006; 22: 642-648. Go to original source... Go to PubMed...
  23. Schussheim A, Diamond J, Philips RA. Left ventricular midwall function improves with antihypertensive therapy and regression of left ventricular hypertrophy in patients with asymptomatic hypertension. Amer J Cardiol 2001; 87: 61-65. Go to original source... Go to PubMed...
  24. Diamond JA, Phillips RA. Hypertensive heart disease. Hypertens Res 2005; 28: 191-202. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.